Functional dyspepsia. Different mechanisms, comprehensive treatment

• Published in: Hastroenterolohii͡a Vol. 51; no. 3; pp. 209 - 212
• Main Authors: A.E. Dorofeyev, N.N. Rudenko, T.E. Kugler
• Format: Journal Article
• Language: English
• Published: Zaslavsky O.Yu 01.09.2017
• Subjects: functional dyspepsia; prokinetics; proton pump inhibitors
• ISSN: 2308-2097; 2518-7880
• DOI: 10.22141/2308-2097.51.3.2017.112639

Functional dyspepsia (FD) is a disease with different prevailing pathogenetic mechanisms. The prevalence of FD varies widely from 10 to 30 % of the population, depending on the country and the surveyed cohort. There are two forms of FD: postprandial distress syndrome manifested by a fullness/early satiety after eating, and epigastric pain syndrome — pain/burning in the epigastrium, which may worsen after eating. In a significant part of patients with FD, there are manifestations of both syndromes, the so-called overlap, or a mixed type. In the Ukrainian population, all patients with dyspepsia should be diagnosed and, if found, — undergo mandatory eradication of H.pylori. In patients with persistent symptoms or in those initially not infected with H.pylori, in our opinion, it is advisable to use the combination of proton pomp inhibitor and prokinetic as starting treatment. In our country, a fixed combination of omeprazole and domperidone is available in two dosages. This is Omez D containing 10 mg of both components and a more highly dosed Omez DSR containing 20 mg of omeprazole and 30 mg of domperidone in the form of sustained-release pellets.